Folgen
Madhan Thamilarasan
Madhan Thamilarasan
Research associate - Senior, Duke University.
Bestätigte E-Mail-Adresse bei duke.edu
Titel
Zitiert von
Zitiert von
Jahr
MicroRNA expression changes during interferon-beta treatment in the peripheral blood of multiple sclerosis patients
M Hecker, M Thamilarasan, D Koczan, I Schröder, K Flechtner, ...
International journal of molecular sciences 14 (8), 16087-16110, 2013
1472013
MicroRNAs in multiple sclerosis and experimental autoimmune encephalomyelitis
M Thamilarasan, D Koczan, M Hecker, B Paap, UK Zettl
Autoimmunity reviews 11 (3), 174-179, 2012
1312012
Integration of MicroRNA databases to study MicroRNAs associated with multiple sclerosis
C Angerstein, M Hecker, BK Paap, D Koczan, M Thamilarasan, ...
Molecular neurobiology 45, 520-535, 2012
602012
Multiple sclerosis: modulation of toll-like receptor (TLR) expression by interferon-β includes upregulation of TLR7 in plasmacytoid dendritic cells
K Derkow, JMJ Bauer, M Hecker, BK Paap, M Thamilarasan, D Koczan, ...
PLoS One 8 (8), e70626, 2013
552013
IL-11 induces encephalitogenic Th17 cells in multiple sclerosis and experimental autoimmune encephalomyelitis
X Zhang, N Kiapour, S Kapoor, T Khan, M Thamilarasan, Y Tao, S Cohen, ...
The Journal of Immunology 203 (5), 1142-1150, 2019
322019
STING Agonist Mitigates Experimental Autoimmune Encephalomyelitis by Stimulating Type I IFN–Dependent and–Independent Immune-Regulatory Pathways
BM Johnson, T Uchimura, MD Gallovic, M Thamilarasan, WC Chou, ...
The Journal of Immunology 206 (9), 2015-2028, 2021
232021
Glatiramer acetate treatment effects on gene expression in monocytes of multiple sclerosis patients
M Thamilarasan, M Hecker, RH Goertsches, BK Paap, I Schröder, ...
Journal of Neuroinflammation 10, 1-12, 2013
202013
Mn Porphyrins as a Novel Treatment Targeting Sickle Cell NOXs to Reverse and Prevent Acute Vaso-Occlusion in Vivo.
M Thamilarasan, R Estupinan, I Batinic-Haberle, R Zennadi
Blood Advances 4 (Issue 11), 2372–2386, 2020
182020
Cilia proteins are biomarkers of altered flow in the vasculature
A Gupta, K Thirugnanam, M Thamilarasan, AM Mohieldin, HT Zedan, ...
JCI Insight, 2022
32022
Restoration of Normal Blood Flow in Mouse Models of Sickle Cell Vaso-Occlusion Following Intravenous or Subcutaneous Administration of a Highly Potent E-Selectin Specific Inhibitor
M Thamilarasan, WE Fogler, JL Magnani, R Zennadi
Blood 136, 17, 2020
12020
MicroRNA detection and quantification in human peripheral blood microvesicles from multiple sclerosis patients treated with interferon-beta-1b
M Thamilarasan, C Angerstein, B Paap, D Koczan, R Goertsches, ...
MULTIPLE SCLEROSIS JOURNAL 17, S500-S501, 2011
12011
Dynamic ex vivo monocyte specific and T cell relevant RNA signatures after glatiramer acetate administration in multiple sclerosis
G Robert, H Michael, T Madhan, K Dirk, HJ Thiesen, UK Zettl
JOURNAL OF NEUROIMMUNOLOGY 228 (1-2), 90-90, 2010
12010
Detection and quantification of microRNA expression in human peripheral blood microvesicles from multiple sclerosis patients treated with interferon-beta-1b
T Madhan, K Dirk, HG Robert, H Michael, T Hans-Juergen, ZU Klaus
JOURNAL OF NEUROIMMUNOLOGY 228 (1-2), 9-9, 2010
12010
Ex vivo genome-wide RNA profiling reveals early and consistent transcriptional regulation within two years of interferon beta-1a sc therapy in relapsing-remitting multiple …
R Goertsches, M Hecker, M Thamilarasan, D Koczan, HJ Thiesen, ...
Multiple Sclerosis 15 (9), S238-S238, 2009
12009
Mn Porphyrin-Based Redox Active Drugs Improve Anemia and Reduce Organ Damage in a Murine Model of Sickle Cell Disease
M Thamilarasan, R Estupinan, R Zennadi
Blood 134, 2255, 2019
2019
Teriflunomide inhibits activation and proliferation of B-cells in patients with relapsing remitting multiple sclerosis (RRMS)
S Markovic-Plese, M Thamilarasan, X Zhang
MULTIPLE SCLEROSIS JOURNAL 25, 303-304, 2019
2019
Mn Porphyrin-Based Redox Active Drugs As Novel Anti-Adhesive and Anti-Inflammatory Agents Targeting Sickle Red Blood Cell Oxidative Damage In Vivo
T Madhan, R Estupinan, R Zennadi
Blood 132, 270, 2018
2018
Expansion of Tregs mediates Murine (m) aCD52 mAb suppression of experimental autoimmune encephalomyelitis (EAE)
N Kiapoor, B Wu, S Kapoor, X Zhang, M Thamilarasan, Y Wan, ...
MULTIPLE SCLEROSIS JOURNAL 24, 1021-1021, 2018
2018
Teriflunomide inhibits activation and proliferation of B-cells in patients with relapsing remitting multiple sclerosis (RRMS)
M Thamilarasan, X Zhang, S Markovic-Plese
MULTIPLE SCLEROSIS JOURNAL 23, 857-858, 2017
2017
IL-11 induces encephalitogenic Th17 cells
N Kiapour, X Zhang, TH Khan, M Thamilarasan, S Kapoor, ...
The Journal of Immunology 198 (1_Supplement), 210.11-210.11, 2017
2017
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20